Tumor Lysis Syndrome following a Single Dose of Nivolumab for Relapsed Small-Cell Lung Cancer

Tumor lysis syndrome (TLS) is an oncologic emergency most frequently associated with initial treatment of hematologic malignancies and high-tumor burden solid tumors such as small-cell lung cancer (SCLC). Most often, TLS is associated with cytotoxic chemotherapy. In the treatment of SCLC, a paradigm...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayes, Sarah Maryon, Wiese, Christine, Schneidewend, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740064/
https://www.ncbi.nlm.nih.gov/pubmed/35082621
http://dx.doi.org/10.1159/000519566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740064/
https://www.ncbi.nlm.nih.gov/pubmed/35082621
http://dx.doi.org/10.1159/000519566

Ejemplares similares